Momentum Bioscience

Momentum Bioscience

Momentum Bioscience is focused on developing rapid tests for bloodstream infection in patients suspected of sepsis. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
CAD12—18m (Dealroom.co estimates Mar 2014.)
Company register number 05594335
Cardiff Wales (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
GBP2009
Revenues<1m
Profit(<1m)
% profit margin(81 %)
  • Edit
DateInvestorsAmountRound
N/A

£230k

Seed

£490k

Seed

£1.7m

Series A

N/A

Series B

£100k

Grant

€2.5m

Grant
Total FundingCAD8.2m

Recent News about Momentum Bioscience

Edit
More about Momentum Bioscience
Edit

Developer of technology for targeted single-molecule enrichment of DNA and RNA based in Herlev, Denmark. The company specializes in DNA enrichment, molecular methods and sequence that permit informed research decisions, empowering scientists to sequence any genetic region for the purpose of determining virus integration, excluding unintended CRISPR edits and closing gaps in otherwise inaccessible regions.

Keywords: Blood Testing, Clinical Specimens, Clinical Specimens Test, In Vitro Diagnostic Testing, Infection Detection, Medical Testing Technology, Rapid Detection, Rapid Test, Sepsis, Sepsis Diagnostics.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Momentum Bioscience

Edit